Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital.

Todd S, Rafferty P, Walker E, Hunter M, Dinsmore WW, Donnelly CM, McCarty EJ, Quah SP, Emerson CR.

Int J STD AIDS. 2017 Oct;28(11):1074-1081. doi: 10.1177/0956462416688127. Epub 2017 Jan 24.

PMID:
28118801
2.

An improvement model to optimise hospital interdisciplinary learning.

McNamara DA, Rafferty P, Fitzpatrick F.

Int J Health Care Qual Assur. 2016 Jun 13;29(5):550-8. doi: 10.1108/IJHCQA-10-2015-0131.

PMID:
27256777
3.

UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015.

Cresswell F, Waters L, Briggs E, Fox J, Harbottle J, Hawkins D, Murchie M, Radcliffe K, Rafferty P, Rodger A, Fisher M.

Int J STD AIDS. 2016 Aug;27(9):713-38. doi: 10.1177/0956462416641813. Epub 2016 Apr 19.

PMID:
27095790
4.

Development of a squamous cell carcinoma mouse model for immunotoxicity testing.

Sominski DD, Rafferty P, Brosnan K, Volk A, Walker M, Capaldi D, Emmell E, Johnson K, Weinstock D.

J Immunotoxicol. 2016;13(2):226-34. doi: 10.3109/1547691X.2015.1045105. Epub 2015 May 22.

PMID:
26001195
5.

Geophysical and hydrogeological characterisation of the impacts of on-site wastewater treatment discharge to groundwater in a poorly productive bedrock aquifer.

Donohue S, McCarthy V, Rafferty P, Orr A, Flynn R.

Sci Total Environ. 2015 Aug 1;523:109-19. doi: 10.1016/j.scitotenv.2015.03.117. Epub 2015 Apr 7.

PMID:
25863501
6.

Treatment of hypertension with chronotherapy: is it time of drug administration?

Stranges PM, Drew AM, Rafferty P, Shuster JE, Brooks AD.

Ann Pharmacother. 2015 Mar;49(3):323-34. doi: 10.1177/1060028014563535. Epub 2014 Dec 16. Review.

PMID:
25515866
7.

Below the disappearing marshes of an urban estuary: historic nitrogen trends and soil structure.

Wigand C, Roman CT, Davey E, Stolt M, Johnson R, Hanson A, Watson EB, Moran SB, Cahoon DR, Lynch JC, Rafferty P.

Ecol Appl. 2014 Jun;24(4):633-49.

PMID:
24988765
8.

Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

Cohen AT, Spiro TE, B├╝ller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators.

N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096.

9.

Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice.

Wu LH, Huang CC, Adhikarakunnathu S, San Mateo LR, Duffy KE, Rafferty P, Bugelski P, Raymond H, Deutsch H, Picha K, Ward CK, Alexoupolou L, Flavell RA, Mbow ML, Susulic VS.

Metabolism. 2012 Nov;61(11):1633-45. doi: 10.1016/j.metabol.2012.04.015. Epub 2012 May 17.

PMID:
22607770
10.

Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice.

Rafferty P, Egenolf D, Brosnan K, Makropoulos D, Jordan J, Meshaw K, Walker M, Volk A, Bugelski PJ.

J Immunotoxicol. 2012 Jan-Mar;9(1):43-55. doi: 10.3109/1547691X.2011.614646.

PMID:
22299716
11.

Development of a murine model of lymph node metastases suitable for immunotoxicity studies.

Egenolf DD, Rafferty P, Brosnan K, Walker M, Jordan J, Makropoulos D, Kavalkovich K, Watson S, Johns L, Volk A, Bugelski PJ.

J Pharmacol Toxicol Methods. 2011 May-Jun;63(3):236-49. doi: 10.1016/j.vascn.2010.12.001. Epub 2010 Dec 13.

PMID:
21156211
12.

Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.

Betschmann P, Bettencourt B, Donnelly-Roberts D, Friedman M, George J, Hirst G, Josephsohn N, Konopacki D, Li B, Maull J, Morytko MJ, Moore NS, Namovic M, Rafferty P, Salmeron-Garcia JA, Tarcsa E, Wang L, Woller K.

Bioorg Med Chem Lett. 2008 Jul 15;18(14):3848-51. doi: 10.1016/j.bmcl.2008.06.055. Epub 2008 Jun 20.

PMID:
18595695
13.

Exploration of intestinal calcium precipitation as a barrier to absorption at high calcium doses.

Goss S, Rafferty P, Prushko J, Gorman E, Taub M, Bogner R.

Pharm Res. 2008 Dec;25(12):2760-8. doi: 10.1007/s11095-008-9640-1. Epub 2008 Jun 17.

PMID:
18560997
14.

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC; MOTIV (MOxifloxacin Treatment IV) Study Group.

Clin Infect Dis. 2008 May 15;46(10):1499-509. doi: 10.1086/587519.

PMID:
18419482
15.

Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonists.

Morytko MJ, Betschmann P, Woller K, Ericsson A, Chen H, Donnelly-Roberts DL, Namovic MT, Jarvis MF, Carroll WA, Rafferty P.

Bioorg Med Chem Lett. 2008 Mar 15;18(6):2093-6. doi: 10.1016/j.bmcl.2008.01.094. Epub 2008 Jan 30.

PMID:
18272365
16.

Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice.

Capocasale RJ, Makropoulos DA, Achuthanandam R, Stowell N, Quinn J, Rafferty PA, O'Brien J, Emmell E, Bugelski PJ.

Cytometry A. 2008 Feb;73(2):148-59. doi: 10.1002/cyto.a.20512.

17.

A simple variable prism with a linear scale.

Walsh G, Rafferty P, Pearce EI.

Optom Vis Sci. 2008 Jan;85(1):67-8. doi: 10.1097/OPX.0b013e31815ed786.

PMID:
18174842
18.

Thienopyridine urea inhibitors of KDR kinase.

Heyman HR, Frey RR, Bousquet PF, Cunha GA, Moskey MD, Ahmed AA, Soni NB, Marcotte PA, Pease LJ, Glaser KB, Yates M, Bouska JJ, Albert DH, Black-Schaefer CL, Dandliker PJ, Stewart KD, Rafferty P, Davidsen SK, Michaelides MR, Curtin ML.

Bioorg Med Chem Lett. 2007 Mar 1;17(5):1246-9. Epub 2006 Dec 9.

PMID:
17188869
19.

A simple new method for the construction of a ptosis crutch.

Walsh G, Rafferty PR, Lapin J.

Ophthalmic Physiol Opt. 2006 Jul;26(4):404-7.

PMID:
16792740
20.

Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.

Tang Y, Nakada MT, Rafferty P, Laraio J, McCabe FL, Millar H, Cunningham M, Snyder LA, Bugelski P, Yan L.

Mol Cancer Res. 2006 Jun;4(6):371-7.

Supplemental Content

Loading ...
Support Center